BUZZ-Australia's Mayne Pharma jumps after legal cost award

Maywood Acquisition Corp. 2 Class A

Maywood Acquisition Corp. 2 Class A

MYX

0.00

** Mayne Pharma's MYX.AX shares jump as much as 8.1% to A$2.55, marking their biggest intraday gain since April 29, on track for a third straight session of gains

** Stock is up 5.6% on the week, heading for its strongest weekly performance in over three weeks

** Pharma company says it has been awarded A$13.3 million ($9.49 million) in legal costs following its successful court action last year against U.S.-based Cosette Pharmaceuticals

** Mayne sued Cosette in June 2025 over its attempted termination of the February 2025 scheme deed, with a court ruling in October 2025 in Mayne’s favour, dismissing all claims and ordering Cosette to pay costs

** Stock down 21.5% YTD

($1 = 1.4008 Australian dollars)


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.